Drug Targeting Organ-Specific Strategies

References 273
[84] Crameri A, Cwirla S, Stemmer WP, Nature Med. 1996, 2, 100–102.
[85] Yang WP, Green K, Pinz SS, Briones AT, Burton DR, Barbas Cr, J. Mol. Biol. 1995, 254, 392–403.
[86] Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM,
Marks C, Marks JD, J. Mol. Biol. 1996, 263, 551–567.
[87] Jackson H, Bacon L, Pedley RB, Derbyshire E, Field A, Osbourn J, Allen D, Br. J. Cancer. 1998,
78, 181–188.
[88] Casson LP, Manser T, J. Exp. Med. 1995, 182, 743–750.
[89] Chester KA, Begent RH, Robson L, Keep P, Pedley RB, Boden JA, Boxer G, Green A, Winter
G, Cochet O, Lancet 1994, 343, 455–456.
[90] Holliger P, Prospero T, Winter G, Proc. Natl Acad. Sci. USA 1993, 90, 6444–6448.
[91] McGuinness BT, Walter G, FitzGerald K, Schuler P, Mahoney W, Duncan AR, Hoogenboom
HR, Nature Biotechnol. 1996, 14, 1149–1154.
[92] Bauer S, Renner C, Juwana JP, Held G, Ohnesorge S, Gerlach K, Pfreundschuh M, Cancer Res.
1999, 59, 1961–1965.
[93] de Haard H, Henderikx P, Hoogenboom HR, Adv. Drug Del. Rev. 1998, 31, 5–31.
[94] Willuda J, Honegger A, Waibel R, Schubiger PA, Stahel R, Zangemeister-Wittke U, Pluckthun
A, Cancer Res. 1999, 59, 5758–5767.
[95] Schumacher TN, Mayr LM, Minor Jr DL, Milhollen MA, Burgess MW, Kim PS, Science 1996, 271,
1854–1857.
[96] Eckert DM, Malashkevich VN, Hong LH, Carr PA, Kim PS, Cell 1999, 99, 103–115.
[97] Michael NP, Chester KA, Melton RG, Robson L, Nicholas W, Boden JA, Pedley RB, Begent RH,
Sherwood RF, Minton NP, Immunotechnology 1996, 2, 47–57.
[98] Baca M, Presta LG, SJ OC, Wells JA, J. Biol. Chem. 1997, 272, 10678–10684.
[99] Jespers LS, Roberts A, Mahler SM, Winter G, Hoogenboom HR, Biotechnology 1994, 12,
899–903.
[100] Beiboer SH, Reurs A, Roovers RC, Arends JW, Whitelegg NR, Rees AR, Hoogenboom HR, J.
Mol. Biol. 2000, 296, 833–849.
[101] Kempeni J, Ann. Rheum. Dis. 1999, 58 (Suppl. 1), I70–I72.
[102] Mayer A, Chester KA, Flynn AA, Begent RH, J. Immunol. Methods 1999, 231, 261–273.
[103] Huls G, Heijnen IA, Cuomo E, van der Linden J, Boel E, van de Winkel JG, Logtenberg T, Cancer
Res. 1999, 59, 5778–5784.
[104] Huls GA, Heijnen IA, Cuomo ME, Koningsberger JC, Wiegman L, Boel E, van der Vuurst de
Vries AR, Loyson SA, Helfrich W, van Berge Henegouwen GP, van Meijer M, de Kruif J, Logtenberg
T, Nature Biotechnol. 1999, 17, 276–281.
[105] Carnemolla B, Neri N, Castellani P, Veirana N, Neri G, Pini A, Winter G ,Zardi L, Int. J. Cancer
1996, 68, 397–405.
[106] Neri D, Carnemolla B, Nissim A, Leprini A, Querze G, Balza E, Pini A, Tarli L, Halin C, Neri P,
Zardi L, Winter G, Nature Biotechnol. 1997, 15, 1271–1275.
[107] Birchler M, Viti F, Zardi L, Spiess B, Neri D, Nature Biotechnol. 1999, 17, 984–988.
[108] Carnemolla B, Castellani P, Ponassi M, Borsi L, Urbini S, Nicolo G, Dorcaratto A, Viale G, Winter
G, Neri D, Zardi L, Am. J. Pathol. 1999, 154, 1345–1352.
[109] Henderikx P, Kandilogiannaki M, Petrarca C, von Mensdorff-Pouilly S, Hilgers JH, Krambovitis
E, Arends JW, Hoogenboom HR, Cancer Res. 1998, 58, 4324–4332.
[110] de Haard HJ, van Neer N, Reurs A, Hufton SE, Roovers RC, Henderikx P, de Bruine AP, Arends
JW, Hoogenboom HR, J. Biol. Chem. 1999, 274, 18218–18230.
[111] Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB, J. Mol.
Biol. 1999, 293, 865–881.
[112] Schneider H, Harbottle RP, Yokosaki Y, Jost P, Coutelle C, FEBS Lett. 1999, 458, 329–332.